Trial Profile
A Multi-center, Human Factors Engineering (HFE) Usability Study in Cystic Fibrosis Patients to Validate the Approved Instructions for Use (IFU) of TOBI Podhaler™ (Tobramycin Inhalation Powder) Using Placebo Capsules.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 May 2016
Price :
$35
*
At a glance
- Drugs Tobramycin (Primary)
- Indications Cystic fibrosis
- Focus Adverse reactions
- Sponsors Novartis Pharmaceuticals Corporation
- 27 May 2016 New trial record